pepdex
← Back to index
042

Teriparatide

Parathyroid-hormone fragment (PTH 1-34). FDA-approved as Forteo for severe osteoporosis. Anabolic for bone — opposite of bisphosphonates.

Healing
Evidence: Strong
Half-life
~1 hour
Route
Subcutaneous
Cycle
Up to 24 months lifetime (FDA limit)
Schedule
Once daily
In plain English

Teriparatide is the active piece of parathyroid hormone (PTH 1-34). FDA-approved as Forteo for severe osteoporosis. Unlike most osteoporosis drugs, it actually builds new bone instead of just slowing bone loss. Daily injection, capped at 24 months total lifetime use per FDA label.

Status & legality
Natty?
Grey area

FDA-approved drug used for severe osteoporosis. Federations don't typically address it.

FDA
Approved

Approved as Forteo (2002) for severe osteoporosis in postmenopausal women, men with primary or hypogonadal osteoporosis, and glucocorticoid-induced osteoporosis.

Compounding
Approved drug

Available as an FDA-approved drug, not a compounded peptide.

WADA
Not listed
Prescribed

Yes — endocrinology and rheumatology providers prescribe it for osteoporosis. 24-month lifetime cap per FDA label.

Who it's for

  • Severe osteoporosis under endocrine care
  • Stress-fracture recovery (off-label)
  • Older adults with high fracture risk

What to expect

  1. Week 1

    Subtle. Some calcium-flux symptoms early.

  2. Week 4

    Bone markers improving on labs.

  3. Week 8

    Cumulative bone density gains over months, not weeks.

How it works (mechanism)

Recombinant first 34 amino acids of parathyroid hormone (PTH 1-34). Intermittent daily dosing favors osteoblast activity over osteoclast activity, building new bone — opposite of bisphosphonates which slow bone breakdown.

Dosing protocol

20 mcg sub-q daily, per FDA label.

Stacks well with

Standalone is the standard medical use

Side effects

01Nausea
02Mild calcium fluctuations
03Headache
04Leg cramps
05Black-box: theoretical osteosarcoma risk (rat data)

When NOT to use

  • Paget's disease
  • Prior radiation to bone
  • Hypercalcemia
  • Active malignancy
  • Pregnancy / nursing

Bloodwork to monitor

  • Serum calcium baseline + at 1 month + every 6 months
  • 25-OH vitamin D

Common mistakes

  • Running past the 24-month FDA lifetime limit
  • Skipping calcium / vitamin D adequacy first
  • Underestimating the prescription-and-monitoring requirement

Drug & supplement interactions

  • Digitalis (digoxin): teriparatide-induced calcium fluctuations may sensitize to digitalis effects
  • Thiazide diuretics: may cause hypercalcemia
  • Lifetime cap of 24 months per FDA label — combine with calcium and vitamin D adequacy

Educational only. User-specific dosing is between you and a qualified provider.

Frequently asked

What is Teriparatide?+
Teriparatide is the active piece of parathyroid hormone (PTH 1-34). FDA-approved as Forteo for severe osteoporosis. Unlike most osteoporosis drugs, it actually builds new bone instead of just slowing bone loss. Daily injection, capped at 24 months total lifetime use per FDA label.
Is Teriparatide FDA approved?+
Approved as Forteo (2002) for severe osteoporosis in postmenopausal women, men with primary or hypogonadal osteoporosis, and glucocorticoid-induced osteoporosis.
Is Teriparatide banned by WADA?+
Teriparatide is not currently on the WADA prohibited list.
Are you still natty after taking Teriparatide?+
Grey area. FDA-approved drug used for severe osteoporosis. Federations don't typically address it.
Do doctors prescribe Teriparatide?+
Yes — endocrinology and rheumatology providers prescribe it for osteoporosis. 24-month lifetime cap per FDA label.
What's the typical dose of Teriparatide?+
20 mcg sub-q daily, per FDA label.
What are the side effects of Teriparatide?+
Common side effects include: Nausea; Mild calcium fluctuations; Headache; Leg cramps. Less common effects and full safety details are on the entry page.
How long until Teriparatide starts working?+
Subtle. Some calcium-flux symptoms early.